New Hunger Drugs Can Reduce Global Obesity, Says ICLDC Expert

A leading expert has told delegates at a major diabetes conference that developing new drugs to regulate appetite in humans can help tackle the global obesity crisis.

Karim Meeran, Chairman of Imperial College London Diabetes Centre’s (ICLDC) Medical Board and Professor of Endocrinology, Imperial College London, was addressing delegates at the Middle East Diabetes Conference at Arab Health 2014.

He explained that humans have evolved to become very successful in increasing food supply and thus reducing the need to exercise.

“The genes that we have always had, which protected us against starvation, are now causing uncontrolled obesity,” he said, adding that humans now have the opportunity to respond more to the brain’s drive to eat without having to hunt for food.

Professor Meeran also described how recent advances in understanding signals sent by the brain relating to hunger, have been demonstrated through bariatric surgery, which is performed to achieve weight loss.

“While advising people to exercise remains hugely important, this often does not work as the urge to eat is very powerful. So we are increasingly developing new drugs that can control hunger.

“In time we hope that these drugs can help reduce the need for bariatric surgery, which like any surgery is traumatic, and even more importantly help tackle the global obesity crisis.”

A recent report on global obesity estimated that there are more than 900 million overweight or obese adults in the developing world, with rates growing faster than in the developed world.

In the UAE figures suggest that more than a third of children are either overweight or obese, while around 1 in 5 adults are also overweight.

Professor Meeran also noted that the conference will have an important focus on the region.

“We know that the Middle East is particularly affected by diabetes and its related complications and recent figures from the International Diabetes Federation (IDF) confirm this.”

“So its vital that subjects covered in this important meeting, like dealing with diabetes during Ramadan, are specifically geared towards the region.”

Recently released figures from the IDF estimate that 18.98 per cent of the UAE population lives with diabetes, placing the country 15th worldwide.

The figures also suggest diabetes is a regional problem with three GCC nations featuring in the top ten countries for diabetes prevalence.

The two-day programme informed GPs, Family Physicians and those dealing with diabetes patients on the best practices for managing diabetes.

The second Middle East Diabetes Conference ran alongside Arab Health 2014 and took its place among 19 specialist conferences accredited by HAAD for Continuing Medical Education (CME).

There were also up-to-date talks looking at trends such as bariatric surgery as a treatment and insulin pump treatment.

The conference is one of several major events being led by ICLDC specialists this year. In fact, the second Clinical Update from the European Society of Endocrinology (ESE), in collaboration with ICLDC, was held earlier this month and featured more than 15 international expert sessions.

Meanwhile the Middle East Diabetes Conference got underway the day after a group of doctors complete the Membership of the Royal College of Physicians (MRCP) part 1 at ICLDC’s Abu Dhabi facility. Further educational events include the Advanced Diabetes Conference on September 26th and 27th this year and a further European Endocrinology Clinical Update on January 16th and 17th 2015. Details on http://icldc.ae

Emirate:  Abu Dhabi

Date: Jan 29, 2014

Back